Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Michael J Brumlik, Benjamin J Daniel, Reinhard Waehler, David T Curiel, Francis J Giles & Tyler J Curiel. (2008) Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy. Expert Opinion on Drug Delivery 5:1, pages 87-103.
Read now
Read now
L. Herrera, C. Stanciu-Herrera, C. Morgan, V. Ghetie & E. S. Vitetta. (2006) Anti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia. Leukemia & Lymphoma 47:11, pages 2380-2387.
Read now
Read now
Samuel Murray & Helena Linardou. (2003) Therapeutic anticancer antibodies. Expert Opinion on Therapeutic Patents 13:2, pages 177-222.
Read now
Read now
Yoav Messinger & Fatih M. Uckun. (1999) A Critical Risk-Benefit Assessment Argues Against the Use of Anthracyclines in Induction Regimens for Newly Diagnosed Childhood Acute Lymphoblastic Leukemia. Leukemia & Lymphoma 34:5-6, pages 415-432.
Read now
Read now
Yoav Messinger, Gregory H. Reaman, Onur Ek & Fatih M. Uckun. (1999) Evaluation of Temozolomide in a SCID Mouse Model of Human B-Cell Precursor Leukemia. Leukemia & Lymphoma 33:3-4, pages 289-293.
Read now
Read now
Articles from other publishers (18)
Hernan Carol, Barbara Szymanska, Kathryn Evans, Ingrid Boehm, Peter J. Houghton, Malcolm A. Smith & Richard B. Lock. (2013) The Anti-CD19 Antibody–Drug Conjugate SAR3419 Prevents Hematolymphoid Relapse Postinduction Therapy in Preclinical Models of Pediatric Acute Lymphoblastic Leukemia. Clinical Cancer Research 19:7, pages 1795-1805.
Crossref
Crossref
Devalingam Mahalingam, Michael J. Brumlik, Reinhard Waehler, David T. Curiel & Tyler J. Curiel. 2013. Cancer Immunotherapy. Cancer Immunotherapy
377
396
.
Barbara Szymanska, Urszula Wilczynska-Kalak, Min H. Kang, Natalia L. M. Liem, Hernan Carol, Ingrid Boehm, Daniel Groepper, C. Patrick Reynolds, Clinton F. Stewart & Richard B. Lock. (2012) Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts. PLoS ONE 7:3, pages e33894.
Crossref
Crossref
Daniel J. Powell & Bruce L. Levine. 2011. Experimental and Applied Immunotherapy. Experimental and Applied Immunotherapy
251
278
.
Paul S. Gaynon & Theresa M. Harned. 2011. New Agents for the Treatment of Acute Lymphoblastic Leukemia. New Agents for the Treatment of Acute Lymphoblastic Leukemia
311
327
.
Arthur E. Frankel, Jung-Hee Woo & David M. Neville. 2009. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy
407
449
.
Valerie I. Brown, Alix E. Seif, Gregor S. D. Reid, David T. Teachey & Stephan A. Grupp. (2008) Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease. Immunologic Research 42:1-3, pages 84-105.
Crossref
Crossref
David T. TeacheyDana A. ObzutJonathan CoopermanJunjie FangMartin CarrollJohn K. ChoiPeter J. HoughtonValerie I. BrownStephan A. Grupp. (2006) The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL. Blood 107:3, pages 1149-1155.
Crossref
Crossref
Natalia L. M. LiemRachael A. PapaChristopher G. MilrossMichael A. SchmidMayamin TajbakhshSeoyeon ChoiCarole D. RamirezAlison M. RiceMichelle HaberMurray D. NorrisKaren L. MacKenzieRichard B. Lock. (2004) Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies. Blood 103:10, pages 3905-3914.
Crossref
Crossref
Arthur E. Frankel, Robert J. Kreitman, Ira Pastan & John R. Murphy. 2003. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy
391
433
.
Wenlei Jiang, Jingen Jiang, Dasheng Xu, Xiang Wang, Shijie Qi, Jun Ouyang, Anlun Ma, Minh Diem Vu, Kupa K. Bilolo & Huifang Chen. (2003) Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat. Microsurgery 23:2, pages 117-122.
Crossref
Crossref
Deborah A Thomas, Jorge Cortes & Hagop M Kantarjian. (2002) New agents in the treatment of acute lymphocytic leukaemia. Best Practice & Research Clinical Haematology 15:4, pages 771-790.
Crossref
Crossref
Arthur E Frankel. (2002) Receptor upregulation enhances cell surface receptor targeted therapies. Leukemia Research 26:12, pages 1069-1071.
Crossref
Crossref
Xavier Thomas. (2002) Nouvelles approches thérapeutiques des leucémies aiguës de l'adulte. Revue Française des Laboratoires 2002:344, pages 55-65.
Crossref
Crossref
A A Pritsa, K T Papazisis, A H Kortsaris, G D Geromichalos & D A Kyriakidis. (2001) Antitumor activity of L-asparaginase from Thermus thermophilus. Anti-Cancer Drugs 12:2, pages 137-142.
Crossref
Crossref
Guillermo Garcia-Manero & Deborah A. Thomas. (2001) Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia. Hematology/Oncology Clinics of North America 15:1, pages 163-205.
Crossref
Crossref
Carolyn A. Felix, Beverly J. Lange & Judith M. Chessells. (2000) Pediatric Acute Lymphoblastic Leukemia: Challenges and Controversies in 2000. Hematology 2000:1, pages 285-302.
Crossref
Crossref
Jacob Post, Wim C. Vooijs, Bert J.E.G. Bast & Gijsbert C. De Gast. (1999) Efficacy of an anti-CD138 immunotoxin and doxorubicin on drug-resistant and drug-sensitive myeloma cells. International Journal of Cancer 83:4, pages 571-576.
Crossref
Crossref